Solventum (SOLV) has been in focus among investors as the stock showed some movement over the past week, catching attention because of changes in its recent performance and valuation. See our latest ...
Healthcare solutions provider Solventum (NYSE:SOLV) will be announcing earnings results this Thursday afternoon. Here’s what to look for. Solventum beat analysts’ revenue expectations by 1.9% last ...
On Thursday, Solventum (NYSE:SOLV) hosted its 2025 Investor Day, during which it outlined its strategic priorities, its business segments, and its long-range plan (LRP) to drive growth and value ...
Hosted on MSN
Solventum: Q4 EPS Beats, Cash Flow Dips
Diversified healthcare company Solventum (NYSE:SOLV) reported fourth-quarter 2024 earnings on Thursday, Feb. 27, that topped analysts' consensus estimates. Adjusted EPS for the quarter came in at ...
Solventum, the recently spun off healthcare arm of 3M, faces challenges in value creation due to stagnant growth, heavy debt burden, and entanglement with its former parent. The company's revenue ...
*Data in the schedule above is intentionally rounded to the nearest million and, therefore, may not sum. 2 Constant currency represents the change in net sales absent the impact on sales from foreign ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback